Australia markets closed

Nurix Therapeutics, Inc. (NRIX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.87+0.13 (+0.63%)
At close: 04:00PM EDT
20.87 0.00 (0.00%)
After hours: 06:43PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/11/2023
30/11/2022
30/11/2021
30/11/2020
30/11/2019
Total revenue
80,887
76,987
38,627
29,750
17,820
-
Operating expenses
Research development
193,337
189,148
184,497
116,434
66,494
-
Selling general and administrative
44,880
42,902
37,997
31,202
16,309
-
Total operating expenses
238,217
232,050
222,494
147,636
82,803
-
Operating income or loss
-157,330
-155,063
-183,867
-117,886
-64,983
-
Income before tax
-144,643
-143,948
-180,360
-117,063
-63,777
-
Income tax expense
-
-
0
131
-20,535
239
Income from continuing operations
-144,733
-143,948
-180,360
-117,194
-43,242
-
Net income
-144,733
-143,948
-180,360
-117,194
-43,242
-
Net income available to common shareholders
-144,733
-143,948
-180,360
-117,194
-43,242
-
Basic EPS
-2.74
-2.65
-3.71
-2.73
-2.76
-
Diluted EPS
-2.74
-2.65
-3.71
-2.73
-2.76
-
Basic average shares
54,152
54,338
48,608
42,895
15,673
-
Diluted average shares
54,152
54,338
48,608
42,895
15,673
-